MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Agrawal, Mridul (BerichterstatterIn) , Hanfstein, Benjamin (BerichterstatterIn) , Erben, Philipp (BerichterstatterIn) , Fabarius, Alice (BerichterstatterIn) , Saußele, Susanne (BerichterstatterIn) , Hofmann, Wolf-Karsten (BerichterstatterIn) , Hehlmann, Rüdiger (BerichterstatterIn) , Müller, Martin Christian (BerichterstatterIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2014
In: Leukemia
Year: 2014, Jahrgang: 28, Heft: 7, Pages: 1478-1485
ISSN:1476-5551
Online-Zugang:Verlag, Volltext: http://www.nature.com/leu/journal/v28/n7/full/leu20146a.html
Volltext
Verfasserangaben:Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C.

MARC

LEADER 00000caa a22000002c 4500
001 1518854184
003 DE-627
005 20220812093159.0
007 cr uuu---uuuuu
008 151027s2014 xx |||||o 00| ||eng c
024 7 |a 10.1038/leu.2014.6  |2 doi 
035 |a (DE-627)1518854184 
035 |a (DE-576)44885418X 
035 |a (DE-599)BSZ44885418X 
035 |a (OCoLC)1340717013 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure  |c Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C. 
264 1 |c 2014 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am: 27.10.2015 
700 1 |a Agrawal, Mridul  |d 1987-  |0 (DE-588)1078043094  |0 (DE-627)837981689  |0 (DE-576)448891107  |4 oth 
700 1 |a Hanfstein, Benjamin  |d 1971-  |0 (DE-588)143353519  |0 (DE-627)645128228  |0 (DE-576)336605587  |4 oth 
700 1 |a Erben, Philipp  |d 1973-  |0 (DE-588)128501014  |0 (DE-627)373920997  |0 (DE-576)297181661  |4 oth 
700 1 |a Fabarius, Alice  |d 1965-  |0 (DE-588)1037001281  |0 (DE-627)751728314  |0 (DE-576)390896667  |4 oth 
700 1 |a Saußele, Susanne  |d 1968-  |0 (DE-588)115839860  |0 (DE-627)69162786X  |0 (DE-576)29010694X  |4 oth 
700 1 |a Hofmann, Wolf-Karsten  |d 1967-  |0 (DE-588)114154635  |0 (DE-627)691208751  |0 (DE-576)351568336  |4 oth 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 oth 
700 1 |a Müller, Martin Christian  |d 1972-  |0 (DE-588)121360296  |0 (DE-627)705409236  |0 (DE-576)181482819  |4 oth 
773 0 8 |i In  |t Leukemia  |d London : Springer Nature, 1997  |g 28(2014), 7, Seite 1478-1485  |h Online-Ressource  |w (DE-627)32046699X  |w (DE-600)2008023-2  |w (DE-576)094139733  |x 1476-5551  |7 nnas  |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure 
773 1 8 |g volume:28  |g year:2014  |g number:7  |g pages:1478-1485  |g extent:8  |a MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure 
856 4 0 |u http://www.nature.com/leu/journal/v28/n7/full/leu20146a.html  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20151027 
993 |a Article 
994 |a 2014 
998 |g 121360296  |a Müller, Martin Christian  |m 121360296:Müller, Martin Christian  |d 60000  |d 61200  |e 60000PM121360296  |e 61200PM121360296  |k 0/60000/  |k 1/60000/61200/  |p 13  |y j 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |e 60000PH1037003489  |k 0/60000/  |p 11 
998 |g 114154635  |a Hofmann, Wolf-Karsten  |m 114154635:Hofmann, Wolf-Karsten  |d 60000  |d 61200  |e 60000PH114154635  |e 61200PH114154635  |k 0/60000/  |k 1/60000/61200/  |p 10 
998 |g 115839860  |a Saußele, Susanne  |m 115839860:Saußele, Susanne  |d 60000  |d 61200  |e 60000PS115839860  |e 61200PS115839860  |k 0/60000/  |k 1/60000/61200/  |p 7 
998 |g 1037001281  |a Fabarius, Alice  |m 1037001281:Fabarius, Alice  |d 60000  |d 61200  |e 60000PF1037001281  |e 61200PF1037001281  |k 0/60000/  |k 1/60000/61200/  |p 6 
998 |g 128501014  |a Erben, Philipp  |m 128501014:Erben, Philipp  |d 60000  |d 61200  |e 60000PE128501014  |e 61200PE128501014  |k 0/60000/  |k 1/60000/61200/  |p 3 
998 |g 143353519  |a Hanfstein, Benjamin  |m 143353519:Hanfstein, Benjamin  |d 60000  |d 61200  |e 60000PH143353519  |e 61200PH143353519  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1078043094  |a Agrawal, Mridul  |m 1078043094:Agrawal, Mridul  |d 60000  |d 61200  |e 60000PA1078043094  |e 61200PA1078043094  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j 
999 |a KXP-PPN1518854184  |e 286924438X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"title":[{"title":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure","title_sort":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failure"}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Agrawal, M.; Hanfstein, B.; Erben, P.; Wolf, D.; Ernst, T.; Fabarius, A.; Saussele, S.; Purkayastha, D.; Woodman, R. C.; Hofmann, W-K; Hehlmann, R.; Hochhaus, A.; Mueller, M. C."]},"note":["Gesehen am: 27.10.2015"],"id":{"doi":["10.1038/leu.2014.6"],"eki":["1518854184"]},"recId":"1518854184","origin":[{"dateIssuedDisp":"2014","dateIssuedKey":"2014"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"person":[{"given":"Mridul","display":"Agrawal, Mridul","family":"Agrawal","role":"oth"},{"given":"Benjamin","family":"Hanfstein","display":"Hanfstein, Benjamin","role":"oth"},{"display":"Erben, Philipp","family":"Erben","role":"oth","given":"Philipp"},{"family":"Fabarius","display":"Fabarius, Alice","role":"oth","given":"Alice"},{"given":"Susanne","role":"oth","family":"Saußele","display":"Saußele, Susanne"},{"family":"Hofmann","display":"Hofmann, Wolf-Karsten","role":"oth","given":"Wolf-Karsten"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"oth","given":"Rüdiger"},{"family":"Müller","display":"Müller, Martin Christian","role":"oth","given":"Martin Christian"}],"relHost":[{"part":{"extent":"8","year":"2014","issue":"7","text":"28(2014), 7, Seite 1478-1485","pages":"1478-1485","volume":"28"},"disp":"MDR1 expression predicts outcome of Ph plus chronic phase CML patients on second-line nilotinib therapy after imatinib failureLeukemia","pubHistory":["Nachgewiesen 11.1997 -"],"type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"32046699X","title":[{"subtitle":"normal and malignant hemopoiesis ; a peer-reviewed journal","title":"Leukemia","title_sort":"Leukemia"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 15.03.04"],"id":{"eki":["32046699X"],"zdb":["2008023-2"],"issn":["1476-5551"]},"origin":[{"publisher":"Springer Nature ; Stockton Press ; Nature Publ. Group","dateIssuedKey":"1997","publisherPlace":"London ; Basingstoke [u.a.] ; Basingstoke","dateIssuedDisp":"1997-"}]}]} 
SRT |a MDR1EXPRES2014